Michelle Dipp - Net Worth and Insider Trading

Michelle Dipp Net Worth

The estimated net worth of Michelle Dipp is at least $9,112 dollars as of 2024-11-10. Michelle Dipp is the CEO of Millendo Therapeutics Inc and owns about 8,596 shares of Millendo Therapeutics Inc (MLND) stock worth over $9,112. Details can be seen in Michelle Dipp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michelle Dipp has not made any transactions after 2016-06-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Michelle Dipp

To

Michelle Dipp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michelle Dipp owns 2 companies in total, including Millendo Therapeutics Inc (MLND) , and Tempest Therapeutics Inc (TPST) .

Click here to see the complete history of Michelle Dipp’s form 4 insider trades.

Insider Ownership Summary of Michelle Dipp

Ticker Comapny Transaction Date Type of Owner
MLND Millendo Therapeutics Inc 2017-06-21 director & Executive Chair
TPST Tempest Therapeutics Inc 2013-06-30 director & 10 percent owner & President & CEO

Michelle Dipp Latest Holdings Summary

Michelle Dipp currently owns a total of 1 stock. Michelle Dipp owns 8,596 shares of Millendo Therapeutics Inc (MLND) as of June 1, 2016, with a value of $9,112.

Latest Holdings of Michelle Dipp

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MLND Millendo Therapeutics Inc 2016-06-01 8,596 1.06 9,112

Holding Weightings of Michelle Dipp


Michelle Dipp Form 4 Trading Tracker

According to the SEC Form 4 filings, Michelle Dipp has made a total of 0 transactions in Millendo Therapeutics Inc (MLND) over the past 5 years. The most-recent trade in Millendo Therapeutics Inc is the acquisition of 1,889 shares on June 1, 2016, which cost Michelle Dipp around $3 Million.

Insider Trading History of Michelle Dipp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michelle Dipp Trading Performance

GuruFocus tracks the stock performance after each of Michelle Dipp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michelle Dipp is -2.18%. GuruFocus also compares Michelle Dipp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michelle Dipp within 3 months outperforms 7 times out of 23 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Michelle Dipp's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Michelle Dipp

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
8 out of 23 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 5.06 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 3.62 LIMIT LIMIT LIMIT LIMIT LIMIT

Michelle Dipp Ownership Network

Ownership Network List of Michelle Dipp

No Data

Ownership Network Relation of Michelle Dipp

Insider Network Chart

Michelle Dipp Owned Company Details

What does Millendo Therapeutics Inc do?

Who are the key executives at Millendo Therapeutics Inc?

Michelle Dipp is the director & Executive Chair of Millendo Therapeutics Inc. Other key executives at Millendo Therapeutics Inc include Chief Medical Officer Christophe Arbet-engels , Chief Development Officer Ryan Zeidan , and director & President and CEO Julia C. Owens .

Millendo Therapeutics Inc (MLND) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Millendo Therapeutics Inc (MLND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Millendo Therapeutics Inc (MLND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Millendo Therapeutics Inc (MLND)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Millendo Therapeutics Inc Insider Transactions

No Available Data

Michelle Dipp Mailing Address

Above is the net worth, insider trading, and ownership report for Michelle Dipp. You might contact Michelle Dipp via mailing address: C/o Ovascience, Inc., 41 Linskey Way, Level B, Cambridge Ma 02142.